Skip to main navigation Skip to search Skip to main content

Role of ivermectin in the treatment of severe orbital myiasis due to Cochliomyia hominivorax.

  • Johanna Osorio
  • , Ligia Moncada
  • , Alejandra Molano
  • , Sandra Valderrama
  • , Sandra Gualtero
  • , Carlos Franco-Paredes
  • Universidad Nacional de Colombia

Research output: Contribution to journalArticlepeer-review

66 Scopus citations

Abstract

We describe 2 patients with severe orbital myiasis due to Cochliomyia hominivorax (of the order Diptera and the family Calliphoridae) who had underlying skin carcinomas and were treated with oral ivermectin and debridement. We suggest that ivermectin plays an important role in the treatment of severe cases of myiasis.

Original languageEnglish
Pages (from-to)e57-59
JournalClinical Infectious Diseases
Volume43
Issue number6
DOIs
StatePublished - 2006
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Role of ivermectin in the treatment of severe orbital myiasis due to Cochliomyia hominivorax.'. Together they form a unique fingerprint.

Cite this